Clinical Trial

Glaucoma Related Quality of Life

Study acronym: GR-QoL
Recruiting
View on ClinicalTrials.gov →
Summary
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-27.
Trial Details
NCT Number NCT07510087
Lead Sponsor Marc Toeteberg-Harms
Conditions Glaucoma
Enrollment 5,000 participants
Start Date 2024-12-30
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-06